In other words, to identify the HER2 in all GC patients, testing pathologists often need to take two steps, performing IHC scoring first and followed by ISH methods in patients showing 2+ , which is undoubtedly technically inconvenient and cumbersome. Here, ERBB2 is linked to gastric cancer.